Bath & Body Works, Inc.: Form 10-Q for the period ended Oct 29, 2011
Filed with the SEC on Dec 2, 2011 and accepted by EDGAR at Dec 2, 2011, 21:31 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2011-10-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2011-07-31 to 2011-10-29 | $2.17bn | us-gaap:SalesRevenueNet |
| Revenue | 9 months2011-01-30 to 2011-10-29 | $6.85bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2011-07-31 to 2011-10-29 | $1.39bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2011-01-30 to 2011-10-29 | $4.32bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2011-07-31 to 2011-10-29 | $785.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2011-01-30 to 2011-10-29 | $2.53bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2011-07-31 to 2011-10-29 | $599.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2011-01-30 to 2011-10-29 | $1.93bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2011-07-31 to 2011-10-29 | $186.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2011-01-30 to 2011-10-29 | $597.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2011-07-31 to 2011-10-29 | $64.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2011-01-30 to 2011-10-29 | $183.0m | us-gaap:InterestExpense |
| Income tax | 3 months2011-07-31 to 2011-10-29 | $28.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2011-01-30 to 2011-10-29 | $156.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2011-07-31 to 2011-10-29 | $94.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2011-01-30 to 2011-10-29 | $491.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2011-07-31 to 2011-10-29 | $310000.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2011-01-30 to 2011-10-29 | $1550000.00 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2011-07-31 to 2011-10-29 | $320000.00 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2011-01-30 to 2011-10-29 | $1600000.00 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2011-07-31 to 2011-10-29 | 308,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2011-01-30 to 2011-10-29 | 317,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2011-01-30 to 2011-10-29 | $94.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2011-01-30 to 2011-10-29 | $338.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2011-01-30 to 2011-10-29 | $491.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2011-01-30 to 2011-10-29 | $1.07bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2011-10-29 | $498.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2011-10-29 | $2.62bn | us-gaap:AssetsCurrent |
| Total assets | At period end2011-10-29 | $6.52bn | us-gaap:Assets |
| Current liabilities | At period end2011-10-29 | $1.50bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2011-10-29 | $3.54bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2011-10-29 | $520.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001445305-11-003514. Last ingested by Listed: Nov 13, 2026, 16:03 ET. Listed shows no prices and gives no investment advice.